(Q45895236)

17 December 2017

title

Expression of PTEN and mTOR in pancreatic neuroendocrine tumors (English)

1 reference

17 December 2017

author name string

Xu Han

1

1 reference

17 December 2017

Yuan Ji

2

1 reference

17 December 2017

Jing Zhao

3

1 reference

17 December 2017

Xuefeng Xu

4

1 reference

17 December 2017

Wenhui Lou

5

1 reference

17 December 2017

publication date

19 May 2013

1 reference

17 December 2017

published in

Tumor Biology

1 reference

17 December 2017

volume

34

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

2871-2879

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s13277-013-0849-1

exact match

0 references

cites work

Endocrine tumours of the pancreas

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Pancreatic Endocrine Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Hepatocellular tumors: immunohistochemical analyses for classification and prognostication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Targeting the mTOR signaling network for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Current development of mTOR inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

FKBP12-Rapamycin-associated Protein (FRAP) Autophosphorylates at Serine 2481 under Translationally Repressive Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

mTOR signaling in growth control and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Phosphatidic acid-mediated mitogenic activation of mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

mTOR signalling in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

The TOR pathway: a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

mTOR, translation initiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

mTOR signaling: implications for cancer and anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

PTEN: one gene, many syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Everolimus for advanced pancreatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Rationale for the use of somatostatin analogs as antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0849-1

Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors.

21 January 2018

1 reference

12 December 2020

Mammalian target of rapamycin: a central node of complex signaling cascades

1 reference

12 December 2020

mTOR activation in well differentiated pancreatic neuroendocrine tumors: a retrospective study on 34 cases

1 reference

12 December 2020

Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors

1 reference

12 December 2020

PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors.

1 reference

12 December 2020

High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.

1 reference

12 December 2020

Surgical treatment of liver metastases in patients with neuroendocrine tumors

1 reference

12 December 2020

Molecular targeted therapy for neuroendocrine tumors

1 reference

12 December 2020

Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells

1 reference

12 December 2020

Molecular pathology of pancreatic neuroendocrine tumors

1 reference

12 December 2020

Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.

1 reference

12 December 2020

10.1007/S13277-013-0849-1

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1008763719

0 references

Fatcat ID

release_g2owfyv6xncbldvuy4esplhhzm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g2owfyv6xncbldvuy4esplhhzm

24 November 2022

mapped directly with Wikidata item

1 reference

17 December 2017